Table: Rohto -2024/25 group results

Rohto Pharmaceutical

13/05/2025 07:34

May 13 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            308.63          270.84         334.50                 
                 (+14.0 pct)     (+13.5 pct)    (+8.4 pct)               
  Operating         38.94           40.05          39.00                 
                 (-2.8 pct)      (+17.9 pct)    (+0.2 pct)               
  Recurring         40.43           42.43          40.50                 
                 (-4.7 pct)      (+19.3 pct)    (+0.2 pct)               
  Net
  Net               31.01           30.94          31.10                 
                 (+0.2 pct)      (+17.3 pct)    (+0.3 pct)               
  EPS            136.11 yen      135.61 yen     137.63 yen               
  EPS Diluted    135.44 yen      135.21 yen                              
  Ann Div         36.00 yen       27.00 yen      42.00 yen               
  -Q2 Div         16.00 yen       12.00 yen      21.00 yen               
  -Q4 Div         20.00 yen       15.00 yen      21.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T